Senores Pharmaceuticals Limited

Pharmaceutical company manufacturing formulations and API with multiple partnerships and facilities.

2017 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Senores Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 59.00 Cr
  • Paid Up Capital ₹ 46.05 Cr
  • Company Age 7 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 161.31 Cr
  • Satisfied Charges ₹ 130.75 Cr
  • Revenue Growth 3.70%
  • Profit Growth 525.22%
  • Ebitda -290.46%
  • Net Worth 13.18%
  • Total Assets 87.70%

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited (SPL) is a Public Limited Indian Non-Government Company incorporated in India on 26 December 2017 (Seven years and four months 16 days old ). Its registered office is in Ahmedabad, Gujarat, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 59.00 Cr and a paid-up capital of Rs 46.05 Cr.

The company currently has active open charges totaling ₹161.31 Cr. The company has closed loans amounting to ₹130.75 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Senores Pharmaceuticals Limited India are Vinay Mishra as COMPANY SECRETARY and Deval Shah as Cfo. Sanjay Majmudar, Jitendra Sanghvi, Manjula Shroff, and Nine other members serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24290GJ2017PLC100263

  • Company No.

    100263

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    26 Dec 2017

  • Date of AGM

    20 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Ahmedabad

Industry

Pharma
Company report

Senores Pharmaceuticals Limited

Explore comprehensive data for Senores Pharmaceuticals Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Senores Pharmaceuticals?

Executive Team (3)

NameDesignationAppointment DateStatus
Swapnil Shah Country flag representing In Managing Director15-Oct-2021Current
Vinay Mishra Country flag representing In Company Secretary21-Nov-2024Current
Deval Shah CFO20-May-2024Current

Board Members (11)

NameDesignationAppointment DateStatus
Ashokbhai Barot Country flag representing In Director 15-May-2018Current
Arpit Shah Country flag representing In Director 10-Nov-2023Current
Sanjay Majmudar Country flag representing In Director 10-Feb-2024Current
Jitendra Sanghvi Country flag representing In Director 23-Nov-2021Current
Manjula Shroff Country flag representing In Director 30-Jan-2024Current
Deval Shah Country flag representing In Whole-Time Director 01-Jan-2020Current

Financial Performance of Senores Pharmaceuticals.

Senores Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.7% increase. The company also saw a substantial improvement in profitability, with a 525.22% increase in profit. The company's net worth Soared by an impressive increase of 13.18%.

Senores Pharmaceuticals revenue growth over time
Senores Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
3.70%
Revenue from Operations
-34.36%
Total Assets
87.70%
Profit or Loss
525.22%
Net Worth
13.18%
EBITDA
-290.46%

What is the Ownership and Shareholding Structure of Senores Pharmaceuticals?

In 2023, Senores Pharmaceuticals had a promoter holding of 63.14% and a public holding of 36.86%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹161.31 Cr

Satisfied Charges

₹130.75 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 111.31 Cr
  • Others : 50.00 Cr

Latest Charge Details

DateLenderAmountStatus
13 Feb 2025Others₹45.00 CrOpen
07 Dec 2024Hdfc Bank Limited₹1.13 MOpen
19 Jul 2023Others₹5.00 CrOpen
31 Dec 2022Hdfc Bank Limited₹111.20 CrOpen
05 Oct 2024Others₹43.55 CrSatisfied

How Many Employees Work at Senores Pharmaceuticals?

Senores Pharmaceuticals has a workforce of 120 employees as of Feb 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Senores Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Senores Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Senores Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Senores Pharmaceuticals

Recent activity within the organization

  • Charges

    A charge registered on 05 Oct 2024 via Charge ID 100984798 with Others was fully satisfied on 17 Mar 2025.

  • Charges

    A charge with Others amounted to Rs. 45.00 Cr with Charge ID 101053565 was registered on 13 Feb 2025.

  • Charges

    A charge registered on 23 Jun 2023 via Charge ID 100762760 with Hdfc Bank Limited was fully satisfied on 12 Feb 2025.

  • Charges

    A charge registered on 03 Apr 2023 via Charge ID 100706667 with Hdfc Bank Limited was fully satisfied on 12 Feb 2025.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 111.20 Cr registered on 31 Dec 2022 with Charge ID 100668335 was modified on 01 Jan 2025.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.11 Cr with Charge ID 101012345 was registered on 07 Dec 2024.

Frequently asked questions

  • What is the Incorporation or founding date of Senores Pharmaceuticals Limited?

    Senores Pharmaceuticals Limited was incorporated on 26 Dec 2017.

  • What is authorized share capital and paid-up capital of Senores Pharmaceuticals Limited?

    The authorized share capital of Senores Pharmaceuticals Limited is ₹ 59.00 Cr and paid-up capital is ₹ 46.05 Cr.

  • Who are the current board members & directors of Senores Pharmaceuticals Limited?

    Currently 14 directors are associated with Senores Pharmaceuticals Limited.

    • Sanjay Shaileshbhai Majmudar
    • Jitendra Babulal Sanghvi
    • Manjula Devi Shroff
    • Deval Rajnikant Shah
    • Ashokbhai Vijaysinh Barot
    • Udayan Dileep Choksi
    • Kalpit Rajesh Gandhi
    • Swapnil Jatinbhai Shah
    • Arpit Deepakkumar Shah
    • Chetan Bipinchandra Shah
    • Hemanshu Nitinchandra Pandya
    • Naresh Bansilal Shah
    • Vinay Kumar Mishra
    • Deval Rajnikant Shah

  • What is the registered address of Senores Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Senores Pharmaceuticals Limited is 1101 To 1103 11Th Floor South Tower One 42 Opp. Jayantilal Park Ambali Bopal Road, India, Ahmedabad, Gujarat, 380054.

  • What is the corporate identification number (CIN) and company number of Senores Pharmaceuticals Limited?

    The corporate identification number (CIN) of Senores Pharmaceuticals Limited is L24290GJ2017PLC100263 and the company number is 100263 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Senores Pharmaceuticals Limited?

    The Official website of Senores Pharmaceuticals Limited is https://www.senorespharma.com

  • What has been the recent revenue trend for Senores Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Senores Pharmaceuticals Limited has risen by 3.70%.

  • How many employees does Senores Pharmaceuticals Limited currently have?

    As Per 2023 financial reports, 120 employees are currently employed by Senores Pharmaceuticals Limited.

  • What change has been observed in the net worth of Senores Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Senores Pharmaceuticals Limited has experienced an upsurge of 13.18%.

  • What are the total open charges for Senores Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Senores Pharmaceuticals Limited amount to ₹ 161.31 Cr.

  • When was the last Balance Sheet of Senores Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Senores Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on API Manufacturers